Drug survival of adalimumab across different manifestations of Behçet's syndrome: a retrospective analysis in 335 patients.
OBJECTIVES Studies on drug survival provide real-world data on efficacy as well as safety. We aimed to evaluate the long-term drug survival of adalimumab (ADA) in a large cohort of patients with Behçet's syndrome (BS). METHODS We conducted a retrospective chart review of 335 BS patients who started ADA between 2008 a...